Learn More
Medchemexpress LLC Zanzalintinib | 2367004-54-2 | C29H25FN4O5 | 10MG

Supplier: Medchemexpress LLC HY13869610MG
Zanzalintinib is an orally active, ATP-competitive multi-receptor tyrosine kinase inhibitor used for preclinical research. It targets MET, VEGFR2, AXL, and MER, with reported cell-based IC50s in the low nanomolar range, and is provided as a research-grade compound (molecular formula C29H25FN4O5; MW 528.53). This compound is for laboratory research only and is not intended for human use.
- Multi-kinase activity against MET, VEGFR2, AXL, and MER.
- Potent cellular activity with low-nanomolar IC50 values.
- Suitable for kinase inhibition and cell-based assays.
- High purity for research applications (>98% reported).
- Stable under recommended storage when protected from light.
- Provided as a solid for preparation of stock solutions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.